Group revenues grew 5.7% year-over-year to PLN 3.56 bn, with net profit up 41.3% to PLN 68.3 m. Strong growth in Medical Operator and Insurance segments offset a slight decline in clinical trials, while regulatory changes and digital expansion remain key themes.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.